Corient Private Wealth LP Cuts Stock Position in Synopsys, Inc. $SNPS

Corient Private Wealth LP trimmed its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 34.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,299 shares of the semiconductor company's stock after selling 9,719 shares during the period. Corient Private Wealth LP's holdings in Synopsys were worth $8,163,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of SNPS. Sankala Group LLC purchased a new stake in Synopsys during the 4th quarter valued at about $25,000. Elevation Wealth Partners LLC lifted its position in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 27 shares during the last quarter. Osbon Capital Management LLC purchased a new stake in shares of Synopsys during the second quarter valued at approximately $25,000. IMG Wealth Management Inc. purchased a new stake in shares of Synopsys during the second quarter valued at approximately $28,000. Finally, Phillip James Consulting Co. purchased a new stake in shares of Synopsys during the fourth quarter valued at approximately $36,000. 85.47% of the stock is currently owned by institutional investors.

Synopsys Stock Up 0.7%

Shares of Synopsys stock opened at $381.17 on Friday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The company has a market cap of $73.05 billion, a P/E ratio of 67.34, a PEG ratio of 2.07 and a beta of 1.23. The company's fifty day simple moving average is $402.34 and its two-hundred day simple moving average is $436.56.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys's revenue was up 42.4% on a year-over-year basis. During the same period in the prior year, the firm earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.97 EPS for the current year.

Wall Street Analysts Forecast Growth

SNPS has been the topic of a number of recent analyst reports. UBS Group set a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. Morgan Stanley dropped their target price on shares of Synopsys from $525.00 to $500.00 and set an "equal weight" rating for the company in a report on Wednesday, August 19th. Zacks Research cut Synopsys from a "strong-buy" rating to a "hold" rating in a research note on Friday, August 21st. Bank of America boosted their price target on Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price target on Synopsys in a research report on Wednesday, May 27th. Thirteen investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $562.67.

Insider Activity at Synopsys

In related news, CEO Sassine Ghazi sold 14,604 shares of the firm's stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the transaction, the chief executive officer owned 76,865 shares of the company's stock, valued at $28,815,151.20. This trade represents a 15.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $419.44, for a total value of $10,335,421.04. Following the transaction, the insider owned 120,443 shares of the company's stock, valued at $50,518,611.92. The trade was a 16.98% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 89,245 shares of company stock worth $37,992,919 over the last 90 days. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Company Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and related services. Its products help semiconductor and electronics companies design, verify, test and manufacture integrated circuits and complex electronic systems.

The company's EDA portfolio includes tools for digital and analog design, simulation, verification, physical implementation, signoff and manufacturing preparation. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, embedded memories and security-related components, which customers can incorporate into system-on-chip designs.

Synopsys additionally offers software integrity and application security solutions that help organizations identify and manage vulnerabilities and risks in the software development lifecycle.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.